Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.20% | $3.92B | €458.08B | 67.61% | 76 Outperform | |
| Roche Holding AG | 1.30% | $2.32B | CHF294.92B | 46.36% | 73 Outperform | |
| AstraZeneca | 1.26% | $2.25B | $324.77B | 32.79% | 80 Outperform | |
| Novartis AG | 1.21% | $2.15B | CHF244.33B | 31.88% | 80 Outperform | |
| HSBC Holdings | 1.16% | $2.07B | £218.16B | 44.94% | 80 Outperform | |
| Nestlé SA | 1.01% | $1.80B | CHF199.86B | 12.45% | 71 Outperform | |
| Toyota Motor | 0.89% | $1.58B | ¥48.39T | 35.36% | 80 Outperform | |
| Shell (UK) | 0.89% | $1.58B | £162.01B | 9.05% | 73 Outperform | |
| Mitsubishi UFJ Financial Group | 0.85% | $1.52B | ¥32.17T | 40.45% | 76 Outperform | |
| Siemens | 0.84% | $1.50B | €183.95B | 8.14% | 74 Outperform |